Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences

Código QR

Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences

Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction associated with (i) chimeric antigen receptor (CAR)-T cell therapy, (ii) therapeutic antibodies, and (iii) haploidentical allogeneic stem cell transplantation (haplo-allo-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tor Henrik Anderson Tvedt, Anh Khoi Vo, Øystein Bruserud, Håkon Reikvam
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	cytokines chimeric antigen receptor therapeutic antibodies haploidentical allogeneic stem cell transplantation Medicine R
Acceso en línea:	https://doaj.org/article/f0af6da2777f473186d1684ee863dffe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Yan-Ruide Li, et al.
Publicado: (2021)

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
por: Deepali K. Bhat, et al.
Publicado: (2021)

Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
por: Jianhua Du, et al.
Publicado: (2021)

CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
por: Yu. N. Lezhnin, et al.
Publicado: (2018)

Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation
por: ZENG Cong, et al.
Publicado: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021)

CAR-T and other adoptive cell therapies for B cell malignancies
por: Peihua Lu, et al.
Publicado: (2021)

Implementing Logic Gates for Safer Immunotherapy of Cancer
por: Mohammed Azharuddin Savanur, et al.
Publicado: (2021)

Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study
por: Kiwan Kim, et al.
Publicado: (2021)

Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
por: Alireza Rajabzadeh, et al.
Publicado: (2021)

How Can We Engineer CAR T Cells to Overcome Resistance?
por: Glover M, et al.
Publicado: (2021)

Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Jessica Waibl Polania, et al.
Publicado: (2021)

Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
por: Léonce Kouakanou, et al.
Publicado: (2021)

Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma
por: Tiantian Ma, et al.
Publicado: (2021)

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Camilla M. Grunewald, et al.
Publicado: (2021)

Hematopoietic stem cell transplantation: clinical use and perspectives
por: Barriga,Francisco, et al.
Publicado: (2012)

Effect of Amnion-Wrapped Allogenic Nerve Bridging on Peripheral Nerve Injury
por: Zhang,Yan-Ru, et al.
Publicado: (2013)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Cristina Aparicio, et al.
Publicado: (2021)

The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
por: Hamilton G, et al.
Publicado: (2021)

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
por: Chunyi Shen, et al.
Publicado: (2021)

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Alessandro Allegra, et al.
Publicado: (2021)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY IMMUNOPATHOLOGICAL STATES. CANCERS AND HEMATOLOGICAL MALIGNANCIES
por: Article Editorial
Publicado: (2015)

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Zhengli Xu, et al.
Publicado: (2021)

A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells
por: Arthur Bister, et al.
Publicado: (2021)

Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
por: Yu-Ge Zhu, et al.
Publicado: (2021)

Femtosecond Laser-assisted Allogenic Additive Stromal Keratoplasty With or Without Excimer Laser Donor Keratomileusis for Management of Keratoconus
por: Mohammad-Reza Jafarinasab, et al.
Publicado: (2021)

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Chung Hyo Kang, et al.
Publicado: (2021)

SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
por: T. S. Nepomnyashchikh, et al.
Publicado: (2017)

Adoptive chimeric antigen receptor T cell (CAR-T) and Treg cell-based immunotherapies: Frontier therapeutic aspects in cancers
por: Mehran Bahraini, et al.
Publicado: (2021)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation
por: Virginia Picanço-Castro, et al.
Publicado: (2021)

CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Leonardo M. R. Ferreira, et al.
Publicado: (2021)

Self-Assembled Nanoparticles Prepared from Low-Molecular-Weight PEI and Low-Generation PAMAM for EGFRvIII-Chimeric Antigen Receptor Gene Loading and T-Cell Transient Modification
por: Yu Q, et al.
Publicado: (2020)

Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
por: E. D. Mikhaltsova, et al.
Publicado: (2021)

CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
por: Pauline Thomas, et al.
Publicado: (2021)

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission
por: Yiyun Wang, et al.
Publicado: (2021)

INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
por: E. R. Chernykh, et al.
Publicado: (2017)

Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
por: Schaefer A, et al.
Publicado: (2021)

Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single‐center retrospective study
por: Wei‐Ran Lv, et al.
Publicado: (2021)

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
por: Niraj Mishra, et al.
Publicado: (2020)